News Column

Nanostring Technologies Inc. Files SEC Form 10-Q, Quarterly Report [Sections 13 Or 15(D)] (Aug. 8, 2014)

August 26, 2014



By a News Reporter-Staff News Editor at Life Science Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Nanostring Technologies Inc. (Form 10-Q) was posted on August 8, 2014.

The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).

There were 13 documents filed with this form. The SEC file number is 0001193125-14-303293.

The contact information for this company is 530 FAIRVIEW AVENUE NORTH, SUITE 2000, SEATTLE WA 98109, 206-378-6266.

Our editors provided additional information about Form 10-Q: The Form 10-Q is a report filed quarterly by most reporting companies. It includes unaudited financial statements and provides a continuing view of the company's financial position during the year. The report must be filed for each of the first three fiscal quarters of the company's fiscal year and is due within 45 days of the close of the quarter.

A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.

For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1401708/0001193125-14-303293-index.html.

Keywords for this news article include: SEC Filing, Nanotechnology, Biological Products, Emerging Technologies, (No Diagnostic Substances), Nanostring Technologies Inc..

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Life Science Weekly


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters